The Straits Times World
WASHINGTON, April 21 - The chief science officer for the U.S. flagship HIV/AIDS program left his role this week and criticized the Trump administration's cuts to foreign assistance and what he said was its use of aid as leverage for U.S. commercial interests.
Go to News Site